DNA
Ginkgo Bioworks Holdings, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +2.2% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +5 | 25.52M | $252.75M | +9 | −4 |
| Q1 2026 | 72 | -1 | 23.15M | $141.95M | +6 | −7 |
| Q4 2025 | 73 | +2 | 24.08M | $200.09M | +2 | — |
| Q3 2025 | 15 | -2 | 16.22M | $236.55M | — | −2 |
| Q2 2025 | 14 | 0 | 15.99M | $179.94M | +2 | −2 |
| Q1 2025 | 11 | -3 | 10.22M | $58.26M | — | −3 |
| Q4 2024 | 14 | +3 | 10.20M | $100.21M | +3 | — |
| Q3 2024 | 10 | -3 | 9.70M | $79.02M | — | −3 |
| Q2 2024 | 13 | — | 419.17M | $140.02M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 3.58M | 0.0% | $40.24M | 0.1% | Held | 5 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (pasivo) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (pasivo) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 1.35M | -5.1% | $15.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (pasivo) | 937.58K | +104.5% | $10.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasivo) | 937.58K | +104.5% | $10.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (pasivo) | 741.05K | +121.0% | $8.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 203.61K | -35.2% | $2.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Glenview Capital ✦ | 149.38K | -20.3% | $1.68M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 87.89K | +18.3% | $990,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 87.89K | +18.3% | $990,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 59.77K | Nuevo | $672,424 | 0.0% | New | 1 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 10.11K | Nuevo | $113,783 | 0.0% | New | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 2.52K | — | $28,310 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 2.52K | — | $28,310 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| D. E. Shaw & Co. | $672,424 | 0.0% |
| Citadel Advisors | $113,783 | 0.0% |
Posición cerrada
| Marshall Wace | $1.50M | era 0.0% |
| Point72 Asset Management | $416,670 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 140 acciones, $0 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 330 acc. · $2,302
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología